According to the deal, a joint development committee with representatives from both the companies will look after AzaSite Xtra development and regulatory submission activities in the US and
LabCorp chief medical officer Dr Mark Brecher said, "MCM is a leading diagnostic laboratory and central lab in Japan with considerable experience and long-standing relationships in the medical
With a dual mechanism of action, the bactericidal, once-daily, injectable lipoglycopeptide antibiotic inhibits bacterial cell wall synthesis and disrupts bacterial cell membrane function. The product is indicated for
Biotech CEO Jason Cranford said, "Partnering with KannaLife Sciences opens up a window to establishing industry standards for phyto-medical products which includes providing certification, quality control and quality
ALX-0761 is the first clinical nanobody candidate resulting from the collaboration between the companies, which began in 2008. Commencement of the single-center, placebo-controlled trial, which is designed to
With original brand name of BI·Sifrol 0.125mg, 0.5mg tablets, Pramipexole hydrochloride 0.125mg tablets DSEP and Pramipexole hydrochloride 0.5mg tablets DSEP are dopamine agonists indicated for the treatment of
Initially, the partnership deals with integrating Greenphire’s global payment platform, eClinicalGPS, with Oracle’s electronic data capture (EDC) solutions, Oracle Health Sciences InForm and Oracle Remote Data Capture (RDC).
Offering an empirically optimized probe database, the software’s design algorithm allows customers to acquire and evaluate designs in an automated setting before making the purchase decision. Roche Sequencing
Empagliflozin belongs to the class of sodium glucose co-transporter-2 (SGLT2) inhibitor compounds, and is being investigated for the reduction of blood glucose levels in adults with type 2
The US FDA approved Procysbi (cysteamine bitartrate) delayed-release capsules on 30 April and is indicated for adults and children with cystinosis aged six years and more. Initial prescription
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.